- $37.09m
- $17.20m
- $12.29m
Aziyo Biologics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aziyo Biologics Q2 Sales Rose 3.9 Percent To $12.6 Million
Aziyo Biologics Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Aziyo Biologics Appoints Randy Mills Chief Executive Officer
U.S. STOCKS ON THE MOVE-Moderna Inc, Nike Inc, Mustang Bio
U.S. STOCKS ON THE MOVE-Kraft Heinz Co, Coinbase, Altria Group
Aziyo rises on leadership changes
Brief: Aziyo Biologics Appoints Randal Mills As Interim President And CEO
NASDAQ RESUMED AT 10:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:40 AM
NASDAQ RESUMED AT 09:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Brief: Aziyo Biologics Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Aziyo Biologics Inc reports results for the quarter ended in March - Earnings Summary
Aziyo Biologics Inc expected to post a loss of 62 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:24 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:20 AM
U.S. RESEARCH ROUNDUP- Autozone, Intel, Teradyne
Aziyo Biologics Inc reports results for the quarter ended in December - Earnings Summary